why choose us

First received: May 31, 2023

Clinical Trial: Safety and Efficacy of Licaminlimab Ophthalmic Suspension for the Treatment of Dry Eye Disease

Study Status: Completed

Recruit Status: RECRUITING

Condition: Dry Eye Disease

Study Type: INTERVENTIONAL


Official Title: A Multi-center, Randomized, Double-Masked, Vehicle-Controlled Study Evaluating the Efficacy and Safety of Licaminlimab for the Treatment of Dry Eye Disease

Brief Summary: The goal of this clinical trial is to learn about licaminlimab (OCS-02) in the treatment of dry eye disease.The main question it aims to answer is if licaminlimab ophthalmic suspension is more effective than vehicle in treating signs of dry eye disease.

Read more